High Tower Advisors, LLC Amarin Corp Plcuk Call Options Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.57 - $0.8 $1,140 - $1,600	2,000 New	2,000 $1,000
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $12,079 - $15,876	-2,990 Reduced 99.67%	10 $0
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $10,920 - $23,280	-3,000 Reduced 50.0%	3,000 $0
Q2 2020 Aug 10, 2020	SELL	$4.78 - $8.26 $15,296 - $26,432	-3,200 Reduced 34.78%	6,000 $2,000
Q1 2020 May 21, 2020	BUY	$4.0 - $21.53 $36,800 - $198,076	9,200 New	9,200 $10,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $27,880 - $48,240	-2,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$13.89 - $23.16 $13,890 - $23,160	-1,000 Reduced 33.33%	2,000 $1,000
Q2 2019 Aug 13, 2019	SELL	$16.27 - $20.51 $4,881 - $6,153	-300 Reduced 9.09%	3,000 $13,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $22,698 - $40,194	1,800 Added 120.0%	3,300 $13,000
Q3 2018 Nov 09, 2018	BUY	$2.45 - $16.27 $3,675 - $24,405	1,500 New	1,500 $17,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.